These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 1910002)

  • 1. Contribution of individual toxin components to virulence of Bacillus anthracis.
    Pezard C; Berche P; Mock M
    Infect Immun; 1991 Oct; 59(10):3472-7. PubMed ID: 1910002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain.
    Cataldi A; Labruyère E; Mock M
    Mol Microbiol; 1990 Jul; 4(7):1111-7. PubMed ID: 2122174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunity induced by Bacillus anthracis toxin-deficient strains.
    Pezard C; Weber M; Sirard JC; Berche P; Mock M
    Infect Immun; 1995 Apr; 63(4):1369-72. PubMed ID: 7890396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Glinert I; Sittner A; Shafferman A; Kobiler D
    Infect Immun; 2012 Aug; 80(8):2623-31. PubMed ID: 22585968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of deletion of the edema factor on Bacillus anthracis pathogenicity in guinea pigs and rabbits.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Glinert I; Sittner A; Kobiler D
    Microb Pathog; 2012 Jan; 52(1):55-60. PubMed ID: 22020310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of Bacillus anthracis mutant strains producing a single toxin component.
    Pezard C; Duflot E; Mock M
    J Gen Microbiol; 1993 Oct; 139(10):2459-63. PubMed ID: 8254316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.
    Ezzell JW; Ivins BE; Leppla SH
    Infect Immun; 1984 Sep; 45(3):761-7. PubMed ID: 6432700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal factor is not required for Bacillus anthracis virulence in guinea pigs and rabbits.
    Levy H; Weiss S; Altboum Z; Schlomovitz J; Rothschild N; Blachinsky E; Kobiler D
    Microb Pathog; 2011 Nov; 51(5):345-51. PubMed ID: 21791242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.
    Chand HS; Drysdale M; Lovchik J; Koehler TM; Lipscomb MF; Lyons CR
    Infect Immun; 2009 Jan; 77(1):429-35. PubMed ID: 18981254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
    Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
    Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
    Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
    Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxins of Bacillus anthracis.
    Brossier F; Mock M
    Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Determination of Lethal Toxin Proteins in Culture Supernatant of Human Live Anthrax Vaccine Bacillus anthracis A16R.
    Zai X; Zhang J; Liu J; Liu J; Li L; Yin Y; Fu L; Xu J; Chen W
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26927174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthrax toxin: a tripartite lethal combination.
    Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
    FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo dynamics of active edema and lethal factors during anthrax.
    Rougeaux C; Becher F; Ezan E; Tournier JN; Goossens PL
    Sci Rep; 2016 Mar; 6():23346. PubMed ID: 26996161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase.
    Tippetts MT; Robertson DL
    J Bacteriol; 1988 May; 170(5):2263-6. PubMed ID: 2834337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.